CWM
BSX icon

Cranbrook Wealth Management’s Boston Scientific BSX Stock Holding History

Cranbrook Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.01K Hold
94
– – ﹤0.01% 351
2026
Q1 		$5.9K Hold
94
– – ﹤0.01% 312
2025
Q4 		$8.96K Hold
94
– – ﹤0.01% 307
2025
Q3 		$9.18K Hold
94
– – ﹤0.01% 306
2025
Q2 		$10.1K Hold
94
– – ﹤0.01% 297
2025
Q1 		$9.48K Sell
94
-25
-21% -$2.52K ﹤0.01% 281
2024
Q4 		$10.6K Buy
119
+94
+376% +$8.28K ﹤0.01% 266
2024
Q3 		$2.1K Buy
+25
New +$1.97K ﹤0.01% 327

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cranbrook Wealth Management's BSX Position: Q2 2026 in Review

Cranbrook Wealth Management held its Boston Scientific (BSX) position steady in Q2 2026 at 94 shares worth $4.01K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

Cranbrook Wealth Management first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.6K in Q4 2024. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cranbrook Wealth Management held 94 shares of Boston Scientific worth $4.01K as of Q2 2026.
  • Cranbrook Wealth Management left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Cranbrook Wealth Management's portfolio in Q2 2026, its #351 holding.
  • Cranbrook Wealth Management first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Cranbrook Wealth Management's Boston Scientific position peaked at $10.6K in Q4 2024.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.